# Dapagliflozin Improves Glycemic Control and Reduces Body Weight as Add-on Therapy to Metformin Plus Sulfonylurea: A 24-Week Randomized, Double-Blind Clinical Trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/dapagliflozin-improves-glycemic-control-and-reduces-body-weight-as-add-on/

## Facts

| Field | Value |
| --- | --- |
| Author Names | S. Matthäei,Keith Bowering,Katja Rohwedder,A Grohl,Shamik Parikh,for the Study 05 Group |
| Citations | 150 |
| DOI | 10.2337/dc14-0666 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2008577165 |
| PMID | 25592197 |
| Type | article |
| Year | 2015 |

## Paper authors

- [Katja Rohwedder](https://scholariq.org/researchers/katja-rohwedder/)

## Paper journal

- [Diabetes Care](https://scholariq.org/journals/diabetes-care/)

## Paper primary topic

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)

## Paper topics

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Diabetes Management and Research](https://scholariq.org/topics/diabetes-management-and-research/)
- [Hyperglycemia and glycemic control in critically ill and hospitalized patients](https://scholariq.org/topics/hyperglycemia-and-glycemic-control-in-critically-ill-and-hospitalized-patients/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.